BM32 vaccine against grass pollen allergy could be potential treatment for hepatitis B infection – News-Medical.Net

Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy.
A team of researchers led by Rudolf Valenta from MedUni Vienna’s Center for Pathophysiology, Infectiology and Immunology has now demonstrated that a protein contained in the BM32 vaccine against grass pollen allergy induces antibodies that prevent the hepatitis B virus from docking onto liver cells. The study has been published in the Lancet EBioMedicine journal.
Chronic hepati…

Click here to view the original article.